Power Law company profile

Zymeworks

Biotech & Life Sciences · Vancouver, Canada · Founded 2003 · IPO 2017 Unicorn

Computational biotechnology company that is focused on optimizing therapeutic antibodies and other protein-based therapeutics

Valuation

$1.84B

Market cap · May/2026

Revenue

$106M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

14 investors on Zymeworks's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 10 investors entered at this stage

Northleaf

Teralys Capital

Lumira Ventures

Fonds de solidarité FTQ

Brace Pharma

Merlin Nexus

BDC Capital

CTI Capital

Business Development Bank of Canada

WUTIF

Series B+ 4 investors entered at this stage

CTI Life Sciences

EcoR1 Capital

Celgene

Eli Lilly

Global footprint

Where Zymeworks has talent and traffic

Workforce by country

8 countries with
team presence

🇨🇦 Canada67.3%

🇺🇸 United States27.7%

🇸🇬 Singapore1.6%

🇮🇪 Ireland1.3%

🇬🇧 United Kingdom1.2%

Top 5 of 8 shown

Web traffic by country

23K monthly visits
across markets

🇨🇦 Canada55.7%

🇺🇸 United States34.8%

🏳️ Korea6.5%

🏳️ Republic of1.7%

🇮🇳 India0.9%

Top 5 markets shown

Patent intelligence

$143M patent portfolio · 88 active families

Estimated portfolio value

$143M

7.8% of market cap · 2.2× smaller than top peer Exact Sciences ($319M)

88 active patent families

Where Zymeworks innovates OncologyCancer researchAntigenBiliary tract carcinomaBiliary tract

Where Zymeworks concentrates vs peers

Each axis is a top-10 topic across Zymeworks and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Zymeworks

An AI-synthesized read of the highest-engagement posts about Zymeworks on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Zymeworks on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles